Shares of Vanda Pharmaceutical (VNDA -11.8%) take a hit in early trading after announcing...

|About: Vanda Pharmaceuticals Inc. (VNDA)|By:, SA News Editor

Shares of Vanda Pharmaceutical (VNDA -11.8%) take a hit in early trading after announcing earlier that it's depression disorder treatment tasimelteon had failed to meet its endpoint in Phase IIb/III trials.